TrialPsychopharmacology2011

Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.

Patrik Roser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.